Journals / Eastern Journal of Medicine / 2019 / Cilt: 24 - Sayı: 3

A Successful Intra-Pleural Fibrinolytic Therapy With Alteplase in A Patient with Empyematous Multiloculated Chylothorax

Pages
379–382
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was complicated with sepsis and multilocated empyema and treated successfully with intra -pleural fibrinolytic therapy using alteplase.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chylothorax is a collection of chyle in the pleural cavity resulting from leakage of lymphatic vessels, usually from the thoracic duct.
📊
Key Findings & Data:Here, we report a case of a 57-year-old man with end stage renal disease and complete central venous stenosis who presented with recurrent right-sided chylothorax.
💡
Conclusion & Impact:It was complicated with sepsis and multilocated empyema and treated successfully with intra -pleural fibrinolytic therapy using alteplase.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Chylothorax is a collection of chyle in the pleural cavity resulting from leakage of lymphatic vessels, usually from the thoracic duct. In majority of cases, chylothorax is a bacteriostatic pleural effusion. Incidence of infected or even empyematous chylothorax are not common. Here, we report a case of a 57-year-old man with end stage renal disease and complete central venous stenosis who presented with recurrent right-sided chylothorax. It was complicated with sepsis and multilocated empyema and treated successfully with intra -pleural fibrinolytic therapy using alteplase.

🔖

Cite This Article

FAİSAL, M., AMİSENO, R., MOHAMMAD, N. (2019). A Successful Intra-Pleural Fibrinolytic Therapy With Alteplase in A Patient with Empyematous Multiloculated Chylothorax. Eastern Journal of Medicine, Cilt: 24 - Sayı: 3, 379–382. https://ajindex.com/articles/222577

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Schild HH, Strassburg CP, Welz A, et al. Treatment Options in Patients With Chylothorax. Deutsches Arzteblatt International 2013; 110: 819-826
  2. Huggins JT. Chylothorax and Cholesterol Pleural Effusion. Journal of National Center of Biotechnology Information. Seminars in Respiratory and Critical Care Medicine 2010; 31: 744-749
  3. Wozniak CJ, Paull DE, Moezzi JE, et al. Choice of first intervention is related to outcomes in the management of empyema. Ann Thorac Surg 2009; 87: 1525-1530
  4. Surinder J, John S. Intra-pleural Fibrinolytic Therapy for Treatment of Adult Parapneumonic Effusions and Empyemas. American College of Chest Physicians 2012; 401-411
  5. Light RW, Sasson CS. Chylothorax and pseudochylothorax. Pleural Diseases. 6th ed. Chapter 23. Philadelphia: Lippincott Williams and Wilkins 2013; 327-343
  6. Kalomedis I. Ocreotide and chylothorax. Curr Opin Pulm Med 2006; 12: 264
  7. Lautin JL, Baran S, Dumitrescu O, et al. Loculated mediastinal chylothorax resulting from esophagogastrectomy: a case report. Journal of Thoracic Imaging 1993; 8: 313-315
  8. Rahman NM, Maskell NA, West A, et al. Intra-pleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection. N Engl J Med 2011; 365: 518-526
  9. Lai C, Mohammad N, Hassan TM, Abdul Hamid MF. Low-dose intrapleural alteplase (without deoxyribonuclease) in complicated parapneumonic effusion: case series and literature reviews. BMJ Case Rep 2017; 2017.